MCK

#2141
McKesson Corporation Common Stock
7.4 3 USD
-1.86%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
7.41
748.47
年范围
7.41
999.00
日变化
-1.86%
每月变动
-99.10%
6个月变化
-99.15%
年变化
-99.07%
前一天收盘价
7.5 7
Open
746.1 4
最低价
7.4 1
High
748.4 7
交易量
1 590
展开完整图表 完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 893.07 M
  • Employee 43 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry 医疗配送
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
22.55
市销率
0.27
每股股息
3.17
股息收益率 %
0.37

McKesson Corporation Common Stock

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

新闻